How antibodies use complement to regulate antibody responses

Molecular Immunology

Volumn 61, Issue 2, 2014, Pages 79-88

  Sörman, Anna ^a   Zhang, Lu ^a   Ding, Zhoujie ^a   Heyman, Birgitta ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Complement receptor 1; Complement receptor 2; IgG3; Mutant IgM

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTIBODY; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; CD81 ANTIGEN; COMPLEMENT; COMPLEMENT COMPONENT C1 RECEPTOR; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C2 RECEPTOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; SERUM AMYLOID P; UNCLASSIFIED DRUG;

ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN ANTIBODY COMPLEX; ANTIGEN PRESENTATION; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; COMPLEMENT ACTIVATION; FOLLICULAR DENDRITIC CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW;

MURINAE; MUS;

COMPLEMENT RECEPTOR 1; COMPLEMENT RECEPTOR 2; IGG3; MUTANT IGM;

ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTIGENS; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNOGLOBULIN M;

EID: 84907883392     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2014.06.010     Document Type: Review

References (122)

1. Abdelmoula M., Spertini F., Shibata T., Gyotoku Y., Luzuy S., Lambert P.H., Izui S. IgG3 is the major source of cryoglobulins in mice. J. Immunol. 1989, 143:526-532.
2. Aguzzi A., Kranich J., Krautler N.J. Follicular dendritic cells: origin, phenotype, and function in health and disease. Trends Immunol. 2014, 35:105-113.
3. Ahearn J.M., Fischer M.B., Croix D., Goerg S., Ma M., Xia J., Zhou X., Howard R.G., Rothstein T.L., Carroll M.C. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996, 4:251-262.
4. Ali Y.M., Lynch N.J., Haleem K.S., Fujita T., Endo Y., Hansen S., Holmskov U., Takahashi K., Stahl G.L., Dudler T., Girija U.V., Wallis R., Kadioglu A., Stover C.M., Andrew P.W., Schwaeble W.J. The lectin pathway of complement activation is a critical component of the innate immune response to pneumococcal infection. PLos Pathogens 2012, 8.
5. Applequist S.E., Dahlström J., Jiang N., Molina H., Heyman B. Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes. J. Immunol. 2000, 165:2398-2403.
6. Arnon T.I., Horton R.M., Grigorova I.L., Cyster J.G. Visualization of splenic marginal zone B-cell shuttling and follicular B-cell egress. Nature 2013, 493:684-688.
7. Barnes N., Gavin A.L., Tan P.S., Mottram P., Koentgen F., Hogarth P.M. FcγRI-deficient mice show multiple alterations to inflammatory and immune responses. Immunity 2002, 16:379-389.
8. Baumgarth N., Herman O.C., Jager G.C., Brown L.E., Herzenberg L.A., Chen J. B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J. Exp. Med. 2000, 192:271-280.
9. Baumgarth N., Tung J.W., Herzenberg L.A. Inherent specificities in natural antibodies: a key to immune defense against pathogen invasion. Springer Semin. Immunopathol. 2005, 26:347-362.
10. Bitter-Suermann D., Hoffmann T., Burger R., Hadding U. Linkage of total deficiency of the second component of the complement system and of genetic C2-polymorphism to the major histocompatibility complex of the guinea pig. J. Immunol. 1981, 127:608-612.
11. Boackle S.A., Holers V.M., Karp D.R. CD21 augments antigen presentation in immune individuals. Eur. J. Immunol. 1997, 27:122-129.
12. Boes M., Esau C., Fischer M.B., Schmidt T., Carroll M., Chen J. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 1998, 160:4776-4787.
13. Botto M., Kirschfink M., Macor P., Pickering M.C., Wurzner R., Tedesco F. Complement in human diseases: lessons from complement deficiencies. Mol. Immunol. 2009, 46:2774-2783.
14. Brockman M.A., Verschoor A., Zhu J., Carroll M.C., Knipe D.M. Optimal long-term humoral responses to replication-defective herpes simplex virus require CD21/CD35 complement receptor expression on stromal cells. J. Virol. 2006, 80:7111-7117.
15. Brown J.S., Hussell T., Gilliland S.M., Holden D.W., Paton J.C., Ehrenstein M.R., Walport M.J., Botto M. The classical pathway is the dominant complement pathway required for innate immunity to Streptococcus pneumoniae infection in mice. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:16969-16974.
16. Brüggemann M., Rajewsky K. Regulation of the antibody response against hapten-coupled erythrocytes by monoclonal anti-hapten antibodies of various isotypes. Cell. Immunol. 1982, 71:365-373.
17. Carey J.B., Moffatt-Blue C.S., Watson L.C., Gavin A.L., Feeney A.J. Repertoire-based selection into the marginal zone compartment during B cell development. J. Exp. Med. 2008, 205:2043-2052.
18. Carlsson F., Getahun A., Rutemark C., Heyman B. Impaired antibody responses but normal proliferation of specific CD4+ T cells in mice lacking complement receptors 1 and 2. Scand. J. Immunol. 2009, 70:77-84.
19. Carroll M.C. The complement system in regulation of adaptive immunity. Nat. Immunol. 2004, 5:981-986.
20. Carroll M.C., Isenman D.E. Regulation of humoral immunity by complement. Immunity 2012, 37:199-207.
21. Carter R.H., Spycher M.O., Ng Y.C., Hoffmann R., Fearon D.T. Synergistic interaction between complement receptor type 2 and membrane IgM on B-lymphocytes. J. Immunol. 1988, 141:457-463.
22. Carter T., Sumiya M., Reilly K., Ahmed R., Sobieszczuk P., Summerfield J.A., Lawrence R.A. Mannose-binding lectin A-deficient mice have abrogated antigen-specific IgM responses and increased susceptibility to a nematode infection. J. Immunol. 2007, 178:5116-5123.
23. Chen F.H., Arya S.K., Rinfret A., Isenman D.E., Shulman M.J., Painter R.H. Domain-switched mouse IgM/Ig2b hybrids indicate individual roles for C mu 2 C mu 3, and C mu 4 domains in the regulation of the interaction of IgM with complement C1q. J. Immunol. 1997, 159:3354-3363.
24. Cherukuri A., Cheng P.C., Pierce S.K. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 2001, 167:163-172.
25. Choi S.C., Wang H.S., Tian L.J., Murakami Y., Shin D.M., Borrego F., Morse H.C., Coligan J.E. Mouse IgM Fc receptor FCMR, promotes B cell development and modulates antigen-driven immune responses. J. Immunol. 2013, 190:987-996.
26. Choi Y.S., Baumgarth N. Dual role for B-1a cells in immunity to influenza virus infection. J. Exp. Med. 2008, 205:3053-3064.
27. Cinamon G., Zachariah M.A., Lam O.M., Foss F.W., Cyster J.G. Follicular shuttling of marginal zone B cells facilitates antigen transport. Nat. Immunol. 2008, 9:54-62.
28. Clarke C.A., Donohoe W.T.A., Woodrow J.C., Finn R., Krevans J.R., Kulke W., Lehane D., Sheppard P.M. Further experimental studies on the prevention of Rh haemolytic disease. Br. Med. J. 1963, 1:979-984.
29. Cooper L.J., Schimenti J.C., Glass D.D., Greenspan N.S. H chain C domains influence the strength of binding of IgG for streptococcal group A carbohydrate. J. Immunol. 1991, 146:2659-2663.
30. Coulie P., Van Snick J. Enhancement of IgG anti-carrier responses by IgG2-anti-hapten antibodies in mice. Eur. J. Immunol. 1985, 15:793-798.
31. Croix D.A., Ahearn J.M., Rosengard A.M., Han S., Kelsoe G., Ma M., Carroll M.C. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 1996, 183:1857-1864.
32. Cutler A.J., Botto M., van Essen D., Rivi R., Davies K.A., Gray D., Walport M.J. T cell-dependent immune response in C1q-deficient mice: defective interferon γ production by antigen-specific T cells. J. Exp. Med. 1998, 187:1789-1797.
33. Czajkowsky D.M., Shao Z. The human IgM pentamer is a mushroom-shaped molecule with a flexural bias. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14960-14965.
34. Da Costa X.J., Brockman M.A., Alicot E., Ma M., Fischer M.B., Zhou X., Knipe D.M., Carroll M.C. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:12708-12712.
35. da Silveira S.A., Kikuchi S., Fossati-Jimack L., Moll T., Saito T., Verbeek J.S., Botto M., Walport M.J., Carroll M., Izui S. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinitiy anti-erythrocyte autoantibody. J. Exp. Med. 2002, 195:665-672.
36. de Jong J.M., Schuurhuis D.H., Ioan-Facsinay A., Welling M.M., Camps M.G., van der Voort E.I., Huizinga T.W., Ossendorp F., Verbeek J.S., Toes R.E. Dendritic cells, but not macrophages or B cells, activate major histocompatibility complex class II-restricted CD4+ T cells upon immune-complex uptake in vivo. Immunology 2006, 119:499-506.
37. Diaz de Ståhl T., Dahlström J., Carroll M.C., Heyman B. A role for complement in feedback-enhancement of antibody responses by IgG3. J. Exp. Med. 2003, 197:1183-1190.
38. Diebolder C.A., Beurskens F.J., de Jong R.N., Koning R.I., Strumane K., Lindorfer M.A., Voorhorst M., Ugurlar D., Rosati S., Heck A.J.R., van de Winkel J.G.J., Wilson I.A., Koster A.J., Taylor R.P., Saphire E.O., Burton D.R., Schuurman J., Gros P., Parren P.W.H.I. Complement is activated by IgG hexamers assembled at the cell surface. Science 2014, 343:1260-1263.
39. Ding Z.J., Bergman A., Rutemark C., Ouchida R., Ohno H., Wang J.Y., Heyman B. Complement-activating IgM enhances the humoral but not the T cell immune response in mice. PLos One 2013, 8.
40. Donius L.R., Handy J.M., Weis J.J., Weis J.H. Optimal germinal center B cell activation and T-dependent antibody responses require expression of the mouse complement receptor Cr1. J. Immunol. 2013, 191:434-447.
41. Ehrenstein M.R., Notley C.A. The importance of natural IgM: scavenger, protector and regulator. Nature Rev. Immunol. 2010, 10:778-786.
42. Ehrenstein M.R., O'Keefe T.L., Davies S.L., Neuberger M.S. Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:10089-10093.
43. Endo Y., Takahashi M., Iwaki D., Ishida Y., Nakazawa N., Kodama T., Matsuzaka T., Kanno K., Liu Y., Tsuchiya K., Kawamura I., Ikawa M., Waguri S., Wada I., Matsushita M., Schwaeble W.J., Fujita T. Mice deficient in ficolin, a lectin complement pathway recognition molecule, are susceptible to streptococcus pneumoniae infection. J. Immunol. 2012, 189:5860-5866.
44. Enriquez-Rincon F., Klaus G.G.B. Differing effects of monoclonal anti-hapten antibodies on humoral responses to soluble or particulate antigens. Immunology 1984, 52:129-136.
45. Fang Y., Xu C., Fu Y.-X., Holers V.M., Molina H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 1998, 160:5273-5279.
46. Ferguson A.R., Youd M.E., Corley R.B. Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int. Immunol. 2004, 16:1411-1422.
47. Fischer M.B., Ma M., Goerg S., Zhou X., Xia J., Finco O., Han S., Kelsoe G., Howard R.G., Rothstein T.L., Kremmer E., Rosen F.S., Carroll M.C. Regulation of the B cell response to T-dependent Ags by classical pathway complement. J. Immunol. 1996, 157:549-556.
48. Gavin A.L., Barnes N., Dijstelbloem H.M., Hogarth P.M. Identification of the mouse IgG3 receptor: Implications for antibody effector function at the interface between innate and adaptive immunity. J. Immunol. 1998, 160:20-23.
49. Getahun A., Dahlström J., Wernersson S., Heyman B. IgG2a-mediated enhancement of Ab- and T-cell responses and its relation to inhibitory and activating FcγRs. J. Immunol. 2004, 172:5269-5276.
50. + B Cells. J. Immunol. 2005, 175:1473-1482.
51. Gommerman J.L., Oh D.Y., Zhou X., Tedder T.F., Maurer M., Galli S.J., Carroll M.C. A role for CD21/CD35 and CD19 in responses to acute septic peritonitis: a potential mechanism for mast cell activation. J. Immunol. 2000, 165:6915-6921.
52. Greenspan N.S., Cooper L.J.N. Intermolecular cooperativity: a clue to why mice have IgG3?. Immunol. Today 1992, 13:164-168.
53. Gustavsson S., Kinoshita T., Heyman B. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T-helper cell induction. J. Immunol. 1995, 154:6524-6528.
54. Guttormsen H.K., Stuart L.M., Shi L., Carroll M.C., Chen J., Kasper D.L., Ezekowitz R.A., Takahashi K. Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. Clin. Immunol. 2009, 130:264-271.
55. Hamano Y., Arase H., Saisho H., Saito T. Immune complex and Fc receptor-mediated augmentation of antigen presentation for in vivo Th cell responses. J. Immunol. 2000, 164:6113-6119.
56. Harte P.G., Cooke A., Playfair J.H.L. Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature 1983, 302:256-258.
57. Hebell T., Ahearn J.M., Fearon D.T. Suppression of the immune response by a soluble complement receptor of B lymphocytes. Science 1991, 254:102-105.
58. Heesters B.A., Chatterjee P., Kim Y.A., Gonzalez S.F., Kuligowski M.P., Kirchhausen T., Carroll M.C. Endocytosis and recycling of immune complexes by follicular dendritic cells enhances B cell antigen binding and activation. Immunity 2013, 38:1164-1175.
59. Henry C., Jerne N. Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J. Exp. Med. 1968, 128:133-152.
60. Hess M.W., Schwendinger M.G., Eskelinen E.L., Pfaller K., Pavelka M., Dierich M.P., Prodinger W.M. Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2 CD21). Blood 2000, 95:2617-2623.
61. Heyman B. Regulation of antibody responses via antibodies, complement, and Fc receptors. Annu. Rev. Immunol. 2000, 18:709-737.
62. Heyman B. Feedback regulation by IgG antibodies. Immunol. Lett. 2003, 88:157-161.
63. Heyman B. Antibody mediated regulation of humoral immunity. Molecular and Cellular Mechanisms of Antibody Activity 2013, 221-248. Springer Science+Business Media, New York. F. Nimmerjahn (Ed.).
64. Heyman B., Pilström L., Shulman M.J. Complement activation is required for IgM-mediated enhancement of the antibody response. J. Exp. Med. 1988, 167:1999-2004.
65. Heyman B., Wiersma E., Nose M. Complement activation is not required for IgG-mediated suppression of the antibody response. Eur. J. Immunol. 1988, 18:1739-1743.
66. Heyman B., Wiersma E.J., Kinoshita T. In vivo inhibition of the antibody response by a monoclonal complement receptor specific antibody. J. Exp. Med. 1990, 172:665-668.
67. Hjelm F., Carlsson F., Getahun A., Heyman B. Antibody-mediated regulation of the immune response. Scand. J. Immunol. 2006, 64:177-184.
68. Hjelm F., Carlsson F., Verbeek S., Heyman B. IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. Scand. J. Immunol. 2005, 62:453-461.
69. Holodick N.E., Vizconde T., Rothstein T.L. B-1a cell diversity: nontemplated addition in B-1a cell Ig is determined by progenitor population and developmental location. J. Immunol. 2014, 192:2432-2441.
70. Honjo K., Kubagawa Y., Jones D.M., Dizon B., Zhu Z., Ohno H., Izui S., Kearney J.F., Kubagawa H. Altered Ig levels and antibody responses in mice deficient for the Fc receptor for IgM (FcmuR). Proc. Natl. Acad. Sci. U.S.A. 2012, 109:15882-15887.
71. Jackson C.G., Ochs H.D., Wedgwood R.J. Immune response of a patient with deficiency of the fourth component of complement and systemic lupus erythematosus. N. Engl. J. Med. 1979, 300:1124-1129.
72. Jayasekera J.P., Moseman E.A., Carroll M.C. Natural antibody and complement mediate neutralization of influenza virus in the absence of prior immunity. J. Virol. 2007, 81:3487-3494.
73. Karlsson M.C.I., Getahun A., Heyman B. FcγRIIB in IgG-mediated suppression of antibody responses: different impact in vivo and in vitro. J. Immunol. 2001, 167:5558-5564.
74. Karlsson M.C.I., Wernersson S., Diaz de Ståhl T., Gustavsson S., Heyman B. Efficient IgG-mediated suppression of primary antibody responses in Fc-gamma receptor-deficient mice. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2244-2249.
75. Karsten C.M., Pandey M.K., Figge J., Kilchenstein R., Taylor P.R., Rosas M., McDonald J.U., Orr S.J., Berger M., Petzold D., Blanchard V., Winkler A., Hess C., Reid D.M., Majoul I.V., Strait R.T., Harris N.L., Kohl G., Wex E., Ludwig R., Zillikens D., Nimmerjahn F., Finkelman F.D., Brown G.D., Ehlers M., Kohl J. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcgammaRIIB and dectin-1. Nat. Med. 2012, 18:1401-1406.
76. Krautler N.J., Kana V., Kranich J., Tian Y.H., Perera D., Lemm D., Schwarz P., Armulik A., Browning J.L., Tallquist M., Buch T., Oliveira-Martins J.B., Zhu C.H., Hermann M., Wagner U., Brink R., Heikenwalder M., Aguzzi A. Follicular dendritic cells emerge from ubiquitous perivascular precursors. Cell 2012, 150:194-206.
77. Kretschmer K., Jungebloud A., Stopkowicz J., Kleinke T., Hoffmann R., Weiss S. The selection of marginal zone B cells differs from that of B-1a cells. J. Immunol. 2003, 171:6495-6501.
78. Kurtz C.B., O' Toole E., Christensen S.M., Weis J.H. The murine complement receptor gene family IV: alternative splicing of Cr2 gene transcripts predicts two distinct gene products that share homologous domains with both human CR2 and CR1. J. Immunol. 1990, 144:3581-3591.
79. Lawrence R.A., Carter T., Bell L.V., Else K.J., Summerfield J., Bickle Q. Altered antibody responses in mannose-binding lectin-A deficient mice do not affect Trichuris muris or Schistosoma mansoni infections. Parasite Immunol. 2009, 31:104-109.
80. Link A., Zabel F., Schnetzler Y., Titz A., Brombacher F., Bachmann M.F. Innate immunity mediates follicular transport of particulate but not soluble protein antigen. J. Immunol. 2012, 188:3724-3733.
81. Mandel T.E., Phipps R.P., Abbot A.P., Tew J.G. Long-term antigen retention by dendritic cells in the popliteal lymph-node of immunized mice. Immunology 1981, 43:353-362.
82. Manderson A.P., Pickering M.C., Botto M., Walport M.J., Parish C.R. Continual low-level activation of the classical complement pathway. J. Exp. Med. 2001, 194:747-756.
83. Matsumoto M., Fukuda W., Circolo A., Goellner J., Strauss-Schoenberger J., Wang X., Fujita S., Hidvegi T., Chaplin D.D., Colten H.R. Abrogation of the alternative complement pathway by targeted deletion of murine factor B. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:8720-8725.
84. Mattsson J., Yrlid U., Stensson A., Schon K., Karlsson M.C., Ravetch J.V., Lycke N.Y. Complement activation and complement receptors on follicular dendritic cells are critical for the function of a targeted adjuvant. J. Immunol. 2011, 187:3641-3652.
85. McLay J., Leonard E., Peterson S., Shapiro D., Greenspan N.S., Schreiber J.R. γ3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides. II. Increased susceptibility to fatal pneumococcal sepsis due to absence of anti-polysaccharide IgG3 is corrected by induction of anti-polysaccharide IgG1. J. Immunol. 2002, 168:3437-3443.
86. Mehlhop E., Diamond M.S. Protective immune responses against West Nile virus are primed by distinct complement activation pathways. J. Exp. Med. 2006, 203:1371-1381.
87. Molina H., Holers V.M., Li B., Fang Y.-F., Mariathasan S., Goellner J., Strauss-Schoenberger J., Karr R.W., Chaplin D.D. Markedly impaired humoral immune responses in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:3357-3361.
88. Na D., Kim D., Lee D. Mathematical modeling of humoral immune response suppression by passively administered antibodies in mice. J. Theor. Biol. 2006, 241:830-851.
89. Nayak A., Pednekar L., Reid K.B., Kishore U. Complement and non-complement activating functions of C1q: a prototypical innate immune molecule. Innate Immun. 2012, 18:350-363.
90. Nimmerjahn F., Ravetch J.V. Divergent immunoglobulin G subclass activity through selective Fc receptor binding. Science 2005, 310:1510-1512.
91. Nimmerjahn F., Ravetch J.V. Fcgamma receptors: old friends and new family members. Immunity 2006, 24:19-28.
92. Nimmerjahn F., Ravetch J.V. Antibody-mediated modulation of immune responses. Immunol. Rev. 2010, 236:265-275.
93. Nose M., Leanderson T. Substitution of asparagine 324 with aspartic acid in the Fc portion of mouse antibodies reduces their capacity for C1q binding. Eur. J. Immunol. 1989, 19:2179-2181.
94. Notley C.A., Brown M.A., Wright G.P., Ehrenstein M.R. Natural IgM is required for suppression of inflammatory arthritis by apoptotic cells. J. Immunol. 2011, 186:4967-4972.
95. ÓNeil K.M., Ochs S.R., Heller S.R., Cork L.C., Morris J.M., Winkelstein J.A. Role of C3 in humoral immunity. Defective antibody production in C3-deficient dogs. J. Immunol. 1988, 140:1939-1945.
96. Ochs H.D., Wedgwood R.J., Frank M.M., Heller S.R., Hosea S.W. The role of complement in the induction of antibody responses. Clin. Exp. Immunol. 1983, 53:208-216.
97. Ochsenbein A.F., Fehr T., Lutz C., Suter M., Brombacher F., Hengartner H., Zinkernagel R.M. Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286:2156-2159.
98. Ouchida R., Mori H., Hase K., Takatsu H., Kurosaki T., Tokuhisa T., Ohno H., Wang J.Y. Critical role of the IgM Fc receptor in IgM homeostasis, B-cell survival, and humoral immune responses. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:E2699-E2706.
99. Pepys M.B. Role of complement in induction of antibody production in vivo: effect of cobra factor and other C3-reactive agents on thymus-dependent and thymus-independent antibody responses. J. Exp. Med. 1974, 140:126-145.
100. Perlmutter R.M., Hansburg D., Briles D.E., Nicolotti R.A., Davie J.M. Subclass restriction of murine anti-carbohydrate antibodies. J. Immunol. 1978, 121:566-572.
101. Prechl J., Baiu D.C., Horvath A., Erdei A. Modeling the presentation of C3d-coated antigen by B lymphocytes: enhancement by CR1/2-BCR co-ligation is selective for the co-ligating antigen. Int. Immunol. 2002, 14:241-247.
102. Quartier P., Potter P.K., Ehrenstein M.R., Walport M.J., Botto M. Predominant role of IgM-dependent activation of the classical pathway in the clearance of dying cells by murine bone marrow-derived macrophages in vitro. Eur. J. Immunol. 2005, 35:252-260.
103. Rubinstein L.J., Stein K.E. Murine immune response to the N. meningitidis group C capsular polysaccharide: ontogeny. J. Immunol. 1988, 141:4352-4356.
104. Ruseva M., Kolev M., Dagnaes-Hansen F., Hansen S.B., Takahashi K., Ezekowitz A., Thiel S., Jensenius J.C., Gadjeva M. Mannan-binding lectin deficiency modulates the humoral immune response dependent on the genetic environment. Immunology 2009, 127:279-288.
105. Rutemark C., Alicot E., Bergman A., Ma M., Getahun A., Ellmerich S., Carroll M.C., Heyman B. Requirement for complement in antibody responses is not explained by the classic pathway activator IgM. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:E934-E942. 10.1073/pnas.1109831108.
106. Rutemark C., Bergman A., Getahun A., Hallgren J., Henningsson F., Heyman B. Complement receptors 1 and 2 in murine antibody responses to IgM-complexed and uncomplexed sheep erythrocytes. PLoS One 2012, 7:e41968.
107. Schmidt R.E., Gessner J.E. Fc receptors and their interaction with complement in autoimmunity. Immunol. Lett. 2005, 100:56-67.
108. Shulman M.J., Collins C., Pennell N., Hozumi N. Complement activation by IgM: evidence for the importance of the third constant domain of the μ heavy chain. Eur. J. Immunol. 1987, 17:549-554.
109. Thiel J., Kimmig L., Salzer U., Grudzien M., Lebrecht D., Hagena T., Draeger R., Volxen N., Bergbreiter A., Jennings S., Gutenberger S., Aichem A., Illges H., Hannan J.P., Kienzler A.K., Rizzi M., Eibel H., Peter H.H., Warnatz K., Grimbacher B., Rump J.A., Schlesier M. Genetic CD21 deficiency is associated with hypogammaglobulinemia. J. Allergy Clin. Immunol. 2012, 129:801-U299.
110. Thornton B.P., Vetvicka V., Ross G.D. Natural antibody and complement-mediated antigen processing and presentation by B-lymphocytes. J. Immunol. 1994, 152:1727-1737.
111. Thornton B.P., Vetvicka V., Ross G.D. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells. Clin. Exp. Immunol. 1996, 104:531-537.
112. Thurnheer M.C., Zuercher A.W., Cebra J.J., Bos N.A. B1 cells contribute to serum IgM, but not to intestinal IgA, production in gnotobiotic Ig allotype chimeric mice. J. Immunol. 2003, 170:4564-4571.
113. Thyphronitis G., Kinoshita T., Inoue K., Schweinle J.E., Tsokos G.C., Metcalf E.S., Finkelman F.D., Balow J.E. Modulation of mouse complement receptors 1 and 2 suppresses antibody responses in vivo. J. Immunol. 1991, 147:224-230.
114. Urbaniak S.J., Greiss M.A. RhD haemolytic disease of the fetus and the newborn. Blood Rev. 2000, 14:44-61.
115. Villiers M.B., Villiers C.L., Jacquier-Sarlin M.R., Gabert F.M., Journet A.M., Colomb M.G. Covalent binding of C3b to tetanus toxin: influence on uptake/internalization of antigen by antigen-specific and non-specific B cells. Immunology 1996, 89:348-355.
116. von Behring E., Wernicke E. Über Immunisierung und Heilung von Versuchstieren bei der Diphterie. Z. Hyg. Infektionskrankheit 1892, 12:10-44.
117. Wernersson S., Karlsson M., Dahlström J., Mattsson R., Verbeek J.S., Heyman B. IgG-mediated enhancement of Ab responses is low in FcRγ chain deficient mice and increased in FcγRII deficient mice. J. Immunol. 1999, 163:618-622.
118. Wiersma E.J., Coulie P.G., Heyman B. Dual immunoregulatory effects of monoclonal IgG-antibodies: suppression and enhancement of the antibody response. Scand. J. Immunol. 1989, 29:439-448.
119. Wiersma E.J., Nose M., Heyman B. Evidence of IgG-mediated enhancement of the antibody response in mice without classical pathway complement activation. Eur. J. Immunol. 1990, 20:2585-2589.
120. Wright J.F., Shulman M.J., Isenman D.E., Painter R.H. C1 binding by murine IgM. The effect of a Pro-to-Ser exchange at residue 436 of the mu-chain. J. Biol. Chem. 1988, 263:11221-11226.
121. Youd M.E., Ferguson A.R., Corley R.B. Synergistic roles of IgM and complement in antigen trapping and follicular localization. Eur. J. Immunol. 2002, 32:2328-2337.
122. Zhang L., Ding Z., Xu H., Heyman B. Marginal zone B cells transport IgG3-immune complexes to splenic follicles. J. Immunol. 2014, in press.